|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.205 USD | -0.41% |
|
-3.31% | -27.19% |
| 07-28 | SNDL Shares Fall After Q2 Swings to Adjusted Operating Loss, Revenue Declines | MT |
| 07-28 | Tranche Update on SNDL Inc.'s Equity Buyback Plan announced on November 4, 2025. | CI |
| Market Cap | 422M 301M 261M 243M 223M 28.61B 426M 2.85B 1.12B 14.31B 1.13B 1.11B 47.41B | P/E 2026 * |
-20x | P/E 2027 * | 170x |
|---|---|---|---|---|---|
| Enterprise Value | 422M 301M 261M 243M 223M 28.61B 426M 2.85B 1.12B 14.31B 1.13B 1.11B 47.41B | EV / Sales 2026 * |
0.46x | EV / Sales 2027 * | 0.46x |
| Free-Float |
95.52% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: SNDL Inc.
| 1 day | -0.41% | ||
| 1 week | -3.31% | ||
| Current month | -1.74% | ||
| 1 month | -7.03% | ||
| 3 months | -16.07% | ||
| 6 months | -19.96% | ||
| Current year | -27.19% |
| 1 week | 1.2 |  | 1.28 |
| 1 month | 1.16 | | 1.36 |
| Current year | 1.16 | | 1.82 |
| 1 year | 1.16 | | 2.89 |
| 3 years | 1.15 | | 2.93 |
| 5 years | 1.15 | | 9.6 |
| 10 years | 1.15 | | 132.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zachary George
CEO | Chief Executive Officer | 48 | 2020-01-29 |
| Director of Finance/CFO | 53 | 2023-06-30 | |
Phil McBride
CTO | Chief Tech/Sci/R&D Officer | 52 | 2024-11-20 |
| Director | Title | Age | Since |
|---|---|---|---|
Gregory Turnbull
BRD | Director/Board Member | 71 | 2018-09-30 |
Greg Mills
CHM | Chairman | 63 | 2019-05-31 |
Zachary George
BRD | Director/Board Member | 48 | 2019-11-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/30/26 | Tax | Company | 100,000 | 0.0384% | ||
| 6/30/26 | Tax | Company | -269,100 | 0.1034% | ||
| 6/16/26 | Option | Director | 28,133 | 0.0109% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.41% | -3.31% | -28.49% | -18.89% | 301M | |
| +0.52% | +2.01% | +57.86% | +159.47% | 1,043B | |
| -0.64% | +0.09% | +50.10% | +47.93% | 621B | |
| -0.99% | -5.39% | +24.06% | +61.99% | 435B | |
| 0.00% | +3.20% | +46.70% | +37.70% | 361B | |
| +0.58% | -1.26% | +35.52% | +39.32% | 293B | |
| -1.55% | -6.84% | +7.20% | +8.86% | 251B | |
| -1.28% | +3.94% | +41.54% | +59.29% | 220B | |
| -0.24% | -11.27% | +1.42% | -46.20% | 201B | |
| -1.32% | -0.93% | +17.94% | +61.22% | 164B | |
| Average | -0.47% | -3.35% | +25.38% | +41.07% | 358.94B | |
| Weighted average by Cap. | -0.23% | -3.79% | +39.94% | +73.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 909M 649M 562M 524M 482M 61.68B 920M 6.15B 2.42B 30.86B 2.44B 2.38B 102B | 925M 660M 571M 533M 490M 62.72B 935M 6.26B 2.46B 31.38B 2.48B 2.42B 104B |
| Net income | -21.59M -15.4M -13.34M -12.43M -11.43M -1.46B -21.83M -146M -57.34M -733M -57.83M -56.56M -2.43B | 2.1M 1.5M 1.3M 1.21M 1.11M 142M 2.12M 14.21M 5.58M 71.25M 5.62M 5.5M 236M |
| Net Debt | - | - |
Employees
2,751
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-06 | US$1.210 | 0.00% | 383,609 |
| 26-08-05 | US$1.210 | 0.00% | 1,340,569 |
| 26-08-04 | US$1.210 | -1.22% | 1,590,677 |
| 26-08-03 | US$1.225 | -0.41% | 3,177,997 |
| 26-07-31 | US$1.230 | -1.60% | 1,871,223 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.696CAD
Average target price
4.932CAD
Spread / Average Target
+190.76%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SNDL Stock
Select your edition
All financial news and data tailored to specific country editions
